VITAL

Vital Chemtech Share Price

 

 

Start SIP in VITAL

Start SIP

Performance

  • Low
  • ₹57
  • High
  • ₹57
  • 52 Week Low
  • ₹48
  • 52 Week High
  • ₹77
  • Open Price₹57
  • Previous Close₹55
  • Volume8,400

Investment Returns

  • Over 1 Month -0.35%
  • Over 3 Month -0.7%
  • Over 6 Month -12.93%
  • Over 1 Year -22.53%

Smart Investing Starts Here Start SIP with Vital Chemtech for Steady Growth!

Invest Now

Vital Chemtech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 33.4
  • PEG Ratio
  • -
  • Market Cap Cr
  • 135
  • P/B Ratio
  • 1.5
  • Average True Range
  • 2.01
  • EPS
  • 1.69
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.41
  • RSI
  • 48.42
  • MFI
  • 32.74

Vital Chemtech Financials

Vital Chemtech Technicals

EMA & SMA

Current Price
₹56.55
+ 1.35 (2.45%)
pointer
  • Bearish Moving Average 14
  • Bullish Moving Average 2
  • 20 Day
  • ₹56.82
  • 50 Day
  • ₹57.52
  • 100 Day
  • ₹58.75
  • 200 Day
  • ₹62.23

Resistance and Support

56.7 Pivot Speed
  • R3 57.30
  • R2 57.15
  • R1 56.85
  • S1 56.40
  • S2 56.25
  • S3 55.95

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Vital Chemtech has an operating revenue of Rs. 296.73 Cr. on a trailing 12-month basis. An annual revenue growth of 34% is outstanding, Pre-tax margin of 5% is okay, ROE of 4% is fair but needs improvement. The company has a reasonable debt to equity of 44%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. It is currently FORMING a base in its weekly chart and is trading around 15% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 13 which is a POOR score indicating inconsistency in earnings, a RS Rating of 51 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 126 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Vital Chemtech Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-14 Quarterly Results & Others To consider other business matters. Final Dividend of Re. 0.50 per equity share.
2025-09-01 To consider ESOP & Others To consider other business matters. Final Dividend of Re. 0.50 per equity share.
2025-05-30 Audited Results & Others To consider other business matters. Final Dividend of Re. 0.50 per equity share.
2024-11-14 Quarterly Results & Others To consider other business matters. Final Dividend of Re. 0.50 per equity share.
2024-05-29 Audited Results & Dividend
Date Purpose Remarks
2024-09-13 FINAL Re.0.00 Final Dividend of Re. 0.50 per equity share.
2023-09-15 FINAL Recommended Final Dividend of 0.5 per equity share. Final Dividend of Re. 0.50 per equity share.
View Vital Chemtech Dividend History Arrow

Vital Chemtech F&O

Vital Chemtech Shareholding Pattern

73.43%
1.78%
20.75%
4.04%

About Vital Chemtech

  • NSE Symbol
  • VITAL
  • BSE Symbol
  • Chairman & Managing Director
  • Mr. Vipul Jatashanker Bhatt
  • ISIN
  • INE0L4K01016

Similar Stocks to Vital Chemtech

Vital Chemtech FAQs

Vital Chemtech share price is ₹56 As on 27 December, 2025 | 08:13

The Market Cap of Vital Chemtech is ₹135.4 Cr As on 27 December, 2025 | 08:13

The P/E ratio of Vital Chemtech is 33.4 As on 27 December, 2025 | 08:13

The PB ratio of Vital Chemtech is 1.5 As on 27 December, 2025 | 08:13

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23